Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
FRTX was delisted on the 18th of December, 2023.
26 hedge funds and large institutions have $6.31M invested in Fresh Tracks Therapeutics, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 12 closing their positions.
28% less funds holding
Funds holding: 36 → 26 (-10)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
31% less capital invested
Capital invested by funds: $9.18M → $6.31M (-$2.87M)
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$91.8K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$46.3K |
| 3 |
AIM
Acrospire Investment Management
Chicago,
Illinois
|
+$34.1K |
| 4 |
RC
RBF Capital
San Francisco,
California
|
+$34.1K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
+$27.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$215K |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
-$161K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$144K |
| 4 |
EGA
Eagle Global Advisors
Houston,
Texas
|
-$112K |
| 5 |
SAIG
Semper Augustus Investments Group
Highlands Ranch,
Colorado
|
-$112K |
FRTX Hedge Fund Activity: Q4 2016 in Review
26 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) for Q4 2016, worth a combined $6.31M — down 31% from $9.18M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of FRTX and 3 opened new positions — a net loss of 9 holders — while 7 trimmed existing stakes and 5 added.
The largest buyer was Renaissance Technologies, adding an estimated $91.8K. The largest seller was ClariVest Asset Management, exiting entirely with an estimated $215K sold.
- 26 institutional investors held Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) as of Q4 2016, down from 36 in Q3 2016.
- Funds reported $6.31M of Fresh Tracks Therapeutics, Inc. Common Stock stock for Q4 2016, down 31% quarter-over-quarter.
- 3 funds opened new Fresh Tracks Therapeutics, Inc. Common Stock positions in Q4 2016 and 12 closed out, a net change of -9 holders.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock buyer in Q4 2016 was Renaissance Technologies, an estimated $91.8K added.
- The largest Fresh Tracks Therapeutics, Inc. Common Stock seller in Q4 2016 was ClariVest Asset Management, an estimated $215K sold.
Based on aggregated 13F filings for Q4 2016.